PT Staff from Pharmacy Times - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	PT Staff Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism		October 2024 Product News - about 2 months ago Pharmacist Spotlight: Anjeza Fero, PharmD, RPh - 3 months ago September 2024 Pharmacy Policy - 3 months ago Product News: August 2024 - 3 months ago Pharmacy Policy, August 2024 - 4 months ago Pharmacist Spotlight: Cassandra Esperant, PharmD, AAHIVP - 5 months ago Condition Watch, June 2024 - 5 months ago June 2024 Products Column - 6 months ago Pharmacist Spotlight: Amina Abubakar, PharmD, AAHIVP - 6 months ago Pharmacy Policy Updates, March 2024 - 8 months ago Pharmacist Spotlight: Natalie Young, PharmD, BCSCP - 8 months ago Condition Watch: Dry Eye Relief - 8 months ago Condition Watch: Migraine - 10 months ago Generic Product News: December 2023 - 12 months ago OTC Product News: December 2023 - 12 months ago Pharmacist Spotlight: Jake Galdo, PharmD, MBA - 12 months ago Pharmacist Spotlight: Joanna Lewis, PharmD, MBA - about 1 year ago Condition State Management: Substance Abuse - about 1 year ago Generic Product News - November 2023 - about 1 year ago Rx Product News - November 2023 - about 1 year ago OTC Product News: November 2023 - about 1 year ago FDA Approves Faricimab for Macular Edema Following Retinal Vein Occlusion - about 1 year ago FDA Approves Mirikizumab for Moderately to Severely Active Ulcerative Colitis - about 1 year ago Subcutaneous Lecanemab Found Equally Effective as IV Version in Alzheimer Disease Treatment - about 1 year ago CDC Issues Alert to Address Shortage of RSV Treatment Nirsevimab - about 1 year ago Phase 3 Trial Begins for Combination Influenza and COVID-19 Vaccine - about 1 year ago Condition State Management: Stroke Watch - about 1 year ago FDA Approves Pentavalent Vaccine for Most Common Serogroups That Cause Meningococcal Disease - about 1 year ago FDA Approves Pembrolizumab Resectable Non–Small Cell Lung Cancer - about 1 year ago FDA Approves Nivolumab for Completely Resected Stage IIB or Stage IIC Melanoma in Adult, Pediatric Patients - about 1 year ago FDA Approves Encorafenib Plus Binimetinib Combination for Non-Small Cell Lung Cancer - about 1 year ago Study Highlights Impact of Preventive Strategies for RSV Hospitalizations in Pediatric Patients - about 1 year ago FDA Issues Emergency Use Authorization to Novavax’s COVID-19 Vaccine 2023-24 Formula - about 1 year ago Menopause Condition Watch - about 1 year ago FDA Approves Momelotinib to Treat Myelofibrosis Patients With Anemia - about 1 year ago